Sumitomo Dainippon Pharma Analysis

Sumitomo Pink Sheet Analysis Notes

About 59.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Sumitomo Dainippon Pharma last dividend was issued on the 30th of March 2023. The entity had 21:20 split on the 26th of March 1992. Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Dai Nippon operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 6987 people.The quote for Sumitomo Dainippon Pharma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Sumitomo Dainippon Pharma call the company at 81 6 6203 5321 or check out https://www.sumitomo-pharma.com.

Sumitomo Dainippon Pharma Investment Alerts

Sumitomo Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.64 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sumitomo Dainippon's market, we take the total number of its shares issued and multiply it by Sumitomo Dainippon's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Sumitomo Profitablity

The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03.

Sumitomo Dainippon Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Sumitomo Dainippon prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sumitomo shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Sumitomo Dainippon. By using and applying Sumitomo Pink Sheet analysis, traders can create a robust methodology for identifying Sumitomo entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

If you are still planning to invest in Sumitomo Dainippon Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sumitomo Dainippon's history and understand the potential risks before investing.